Patents by Inventor Michael G. Parker

Michael G. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230014425
    Abstract: This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.
    Type: Application
    Filed: September 9, 2022
    Publication date: January 19, 2023
    Inventors: David E. McAnany, Michael G. Parker, Sarah D. Mccue
  • Patent number: 11471400
    Abstract: This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: October 18, 2022
    Assignee: Hikma Pharmaceuticals International Limited
    Inventors: David E. McAnany, Michael G. Parker, Sarah D. McCue
  • Publication number: 20220023201
    Abstract: This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Inventors: David E. McAnany, Michael G. Parker, Sarah D. McCue
  • Patent number: 11213480
    Abstract: This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: January 4, 2022
    Assignee: Hikma Pharmaceuticals International Limited
    Inventors: David E. McAnany, Michael G. Parker, Sarah D. McCue
  • Patent number: 10278893
    Abstract: The invention disrupts the paradigm of the side entrance within the field of saunas, steam rooms and therapeutic chambers. The invention reorients the entrance from a door in the side of a therapeutic chamber, as is the situation in the prior art, and places the point of ingress and egress to the bottom or floor of the chamber. Without a side entry door, much less heat is lost when individuals enter and exit the chamber. Furthermore, this invention creates the opportunity for 360 degree seating in steam rooms and saunas, which is exemplified in the embodiment of the prototype named Steam Egg, which is a ten and a half foot tall freestanding egg shaped, mirror covered, steam room that is entered through a hole in the bottom, hovering 33.5 inches off the ground stabilized on three steel legs.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: May 7, 2019
    Inventor: Michael G. Parker
  • Patent number: 9901576
    Abstract: Stable phenobarbital sodium solutions for injection that do not generate impurities during extended storage. These solutions include phenobarbital sodium in an amount of 15 to 200 mg/mL; a C1-C4 alcohol such as ethanol in an amount of 105 to 160 mg/mL; and a glycol such as propylene glycol in an amount of between 620 and 830 mg/mL and have a pH of between 9 and 12 which is adjusted to that range by adding acid or base, as required. No more than 50 mg/mL water is present including any water introduced by the acid or base. The solutions contain no more than 0.8% of phenyl ethyl acetyl urea impurity as well as no detectable amount of phenyl butyric acid after two years storage at room temperature.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: February 27, 2018
    Assignee: West-Ward Pharmaceuticals International Limited
    Inventors: Michael G. Parker, Scott S. Wilson, Yasmeen Chahal, Kelly W. Hovius, David E. McAnany
  • Publication number: 20170143719
    Abstract: Stable phenobarbital sodium solutions for injection that do not generate impurities during extended storage. These solutions include phenobarbital sodium in an amount of 15 to 200 mg/mL; a C1-C4 alcohol such as ethanol in an amount of 105 to 160 mg/mL; and a glycol such as propylene glycol in an amount of between 620 and 830 mg/mL and have a pH of between 9 and 12 which is adjusted to that range by adding acid or base, as required. No more than 50 mg/mL water is present including any water introduced by the acid or base. The solutions contain no more than 0.8% of phenyl ethyl acetyl urea impurity as well as no detectable amount of phenyl butyric acid after two years storage at room temperature.
    Type: Application
    Filed: November 18, 2016
    Publication date: May 25, 2017
    Inventors: Michael G. Parker, Scott S. Wilson, Yasmeen Chahal, Kelly W. Hovius, David E. McAnany
  • Publication number: 20130042402
    Abstract: The invention disrupts the paradigm of the side entrance within the field of saunas, steam rooms and therapeutic chambers. The invention reorients the entrance from a door in the side of a therapeutic chamber, as is the situation in the prior art, and places the point of ingress and egress to the bottom or floor of the chamber. Without a side entry door, much less heat is lost when individuals enter and exit the chamber. Furthermore, this invention creates the opportunity for 360 degree seating in steam rooms and saunas, which is exemplified in the embodiment of the prototype named Steam Egg, which is a ten and a half foot tall freestanding egg shaped, mirror covered, steam room that is entered through a hole in the bottom, hovering 33.5 inches off the ground stabilized on three steel legs.
    Type: Application
    Filed: August 20, 2012
    Publication date: February 21, 2013
    Inventor: Michael G. Parker